Petros Pharmaceuticals, Inc.
PTPI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14,319 | -$8,163 | -$20,038 | -$8,987 |
| Dep. & Amort. | $2,944 | $3,415 | $5,716 | $6,878 |
| Deferred Tax | $0 | $0 | $0 | -$9,481 |
| Stock-Based Comp. | $197 | $417 | $1,195 | $1,305 |
| Change in WC | $4,527 | $625 | -$3,302 | -$1,764 |
| Other Non-Cash | $4,048 | -$3,921 | $3,631 | $187 |
| Operating Cash Flow | -$2,603 | -$7,627 | -$12,797 | -$11,862 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$25 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$25 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$765 | -$1,464 | -$1,624 | -$7,188 |
| Stock Issued | $0 | $0 | $0 | $21,745 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$1,292,916 | $0 | $0 | $0 |
| Other Fin. Act. | $1,286,682 | $13,001 | $0 | $4,012 |
| Financing Cash Flow | -$6,999 | $11,537 | -$1,624 | $18,570 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$9,627 | $3,911 | -$14,421 | $6,708 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $13,337 | $9,426 | $23,848 | $17,140 |
| End Cash | $3,710 | $13,337 | $9,426 | $23,848 |
| Free Cash Flow | -$2,628 | -$7,627 | -$12,797 | -$11,862 |